CTKBCytek Biosciences, Inc.
4.810USD+2.34%Mkt Cap: 625.22M $P/E:

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lig…

Key Statistics

Company
Market Cap625.22M $
Enterprise Value370.18M $
Revenue (TTM)206.71M $
Gross Profit104.46M $
Net Income (TTM)-66.54M $
Revenue/Share1.609 USD
Last Price4.810 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees682
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)66.57
PEG
EV/EBITDA-9.31
EV/Revenue1.79
P/S2.93
P/B1.88
EPS (TTM)-0.62
EPS (Forward)0.07
52W Range
3.28053% of range6.180
52W High6.180 USD
52W Low3.280 USD
Profitability
Gross Margin51.84%
Oper. Margin-29.50%
EBITDA Margin-19.23%
Profit Margin-33.02%
ROE-19.47%
ROA-14.42%
Growth
Revenue Growth5.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-4.69M $
CapEx (TTM)4.19M $
FCF Margin4.50%
FCF Yield1.49%
Net Debt-235.54M $
Net Debt/EBITDA5.92
Balance Sheet
Debt/Equity0.07
Current Ratio4.48
Quick Ratio3.71
Book Value/Sh2.477 USD
Cash/Share2.016 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.563 USD
Upside (mean)+15.6%
Target Range4.750 USD7.500 USD
$4.750+15.6% to mean$7.500
# Analysts4
Ownership
Shares Out.129.98M
Float103.08M
Insiders8.36%
Institutions63.13%
Short Interest
Short Ratio6.1d
Short % Float4.76%
Short % Out.3.77%
Shares Short4.90M
Short (prev mo.)3.51M
Technical
SMA 504.417 (+8.9%)
SMA 2004.607 (+4.4%)
Beta1.17
S&P 52W Chg18.16%
Avg Vol (30d)796.35K
Avg Vol (10d)885.07K
Technical Indicators
RSI (14)57.9
MACD0.0888
MACD Signal0.0512
MACD Hist.+0.0375
BB Upper4.938 USD
BB Middle4.484 USD
BB Lower4.029 USD
BB Width20.26%
ATR (14)0.2158 USD
Vol Ratio (20d)1.11x